Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Jane Griffiths

- PMLiVE

Janssen’s quest to prevent diseases taking hold

Johan van Hoof, general manager of Janssen Vaccines & Prevention, on 'recalibrating' public understanding of illness

Janssen’s quest to prevent diseases taking hold

Johan van Hoof, general manager of Janssen Vaccines & Prevention, on 'recalibrating' public understanding of illness

- PMLiVE

Janssen develops digital tools to help automate clinical trials

iSTEP platform combines mobile tech and smart packaging

- PMLiVE

CHMP recommends Teva’s generic version of Astellas’ Advagraf

Committee backs the drug for transplant rejection prophylaxis

- PMLiVE

SMC backtracks on Janssen’s multiple myeloma treatment Darzalex

Will now recommend the first-in-class treatment after securing a discount

- PMLiVE

Janssen’s Imbruvica fails to win NICE backing in lymphoma

But the agency recommends it on the CDF for another type of cancer

- PMLiVE

Janssen wins European approval for Symtuza

European Commission approves the drug to treat HIV-1

FDA approves Medtronic’s tablet-controlled pain device

The Intellis system can be programmed via a Samsung's Galaxy S2

- PMLiVE

FDA approves Medtronic’s tablet-controlled pain device

The Intellis system can be programmed via a Samsung's Galaxy S2

- PMLiVE

Janssen launches UK blood cancer awareness campaign

The pharma group join forces with designer to set up ‘giant’ names in London

Google: We’re not a big healthcare company… yet

Alphabet's Eric Schmidt on where his company currently sits within the life sciences landscape

Shift to value-based medicine will boost mHealth uptake

Advances in devices and network coverage will also both contribute, say analysts

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links